|
News for: |
|
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
FDA Approval Activities for this Drug…
Malarone (atovaquone and proguanil hydrochloride) Tablets, GlaxoSmithKline NDA 21-078/S3 8/2/02 8/12/02 8/5/02 Malarone (atovaquone and proguanil hydrochloride) Tablets, GlaxoSmithKline NDA 21-078/S1 2/28/02 3/7/02 Malarone (atovaquone and proguanil hydrochloride) Tablets, Glaxo Wellcome NDA 21-078 7/14/00 6/16/03 Malarone Indications: For treatment and prevention of Plasmodium falciparum malaria. Mepron (atovaquone) Suspension, Glaxo Wellcome NDA 20-500/S-005 Malarone (atovaquone and proguanil hydrochloride) Tablets, GlaxoSmithKline ATOVAQUONE; PROGUANIL HYDROCHLORIDE Tablet; 250MG;100MG MALARONE GLAXOSMITHKLINE 021078 ATOVAQUONE; PROGUANIL HYDROCHLORIDE Tablet; 62.5MG;25MG MALARONE PEDIATRIC GLAXOSMITHKLINE Malarone (atovaquone and proguanil hydrochloride) Tablets, GlaxoSmithKline, Labeling Revision | Malarone (atovaquone and proguanil hydrochloride) Tablets, GlaxoSmithKline, Labeling Revision | Malarone (atovaquone and proguanil hydrochloride) Tablets, GlaxoSmithKline, Labeling Revision
|